Novel use of fine needle aspiration (FNA) biopsy to diagnose cervical cancer in a low-resource setting: A case series Morovia, Liberia

David Alele; Bernice Dahn; Sia Camanor; Edet Ikpi; Molly Lieber; Andrew Dottino; Billy Johnson; Etedafe P Gharoro; Ann Marie Beddoe

doi:10.1002/ccr3.2911

Novel use of fine needle aspiration (FNA) biopsy to diagnose cervical cancer in a low-resource setting: A case series Morovia, Liberia

Clin Case Rep. 2020 May 17;8(8):1413-1418. doi: 10.1002/ccr3.2911. eCollection 2020 Aug.

Authors

David Alele^{1

2

3}, Bernice Dahn⁴, Sia Camanor¹, Edet Ikpi^{1

2

3}, Molly Lieber², Andrew Dottino², Billy Johnson¹, Etedafe P Gharoro^{1

2

3}, Ann Marie Beddoe²

Affiliations

¹ JFK Memorial Hospital Monrovia Liberia.
² Icahn School of Medicine Mount Sinai Medical Center New York NY USA.
³ Liberian College of Physicians and Surgeons Monrovia Liberia.
⁴ A.M. Dogliotti School of Medicine Monrovia Liberia.

Abstract

The role of pathology in improving cancer in resource-limited countries is essential, yet many barriers exist. FNA is a rapid, low-cost and efficient method for diagnosing cancer, planning treatment, and building a cancer registry.

Keywords: adenocarcinoma; cervical cancer; cytology; fine needle aspiration (FNA); low‐ and middle‐income countries (LMICs); squamous cell cancer.

Publication types

Case Reports